Management of Gastrointestinal Disorders in Children with HIV Infection

[1]  P. Volberding,et al.  Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. , 2004, The New England journal of medicine.

[2]  R. B. Canani,et al.  HIV Infection: Working Group Report of the Second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition , 2004, Journal of pediatric gastroenterology and nutrition.

[3]  J. Overbaugh,et al.  Predictors of Early Mortality in a Cohort of Human Immunodeficiency Virus Type 1-Infected African Children , 2004, The Pediatric infectious disease journal.

[4]  B. Gazzard,et al.  Effect of Octreotide on Small Intestinal Motility in HIV-Infected Patients with Chronic Refractory Diarrhea , 2001, Digestive Diseases and Sciences.

[5]  A. Rubino,et al.  In Vivo and in Vitro Efficacy of Octreotide for Treatment of Enteric Cryptosporidiosis , 1998, Digestive Diseases and Sciences.

[6]  M. Sharland,et al.  Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland , 2003, BMJ : British Medical Journal.

[7]  M. Lindegren,et al.  Changes in deaths reported with human immunodeficiency virus infection among United States children less than thirteen years old, 1987 through 1999 , 2003, The Pediatric infectious disease journal.

[8]  J. Montaner,et al.  Hepatotoxicity of nucleoside reverse transcriptase inhibitors. , 2003, Seminars in liver disease (Print).

[9]  Mark A. Miller,et al.  Global Illness and Deaths Caused by Rotavirus Disease in Children , 2003, Emerging infectious diseases.

[10]  T. Miller.  Nutritional aspects of HIV-infected children receiving highly active antiretroviral therapy , 2003, AIDS.

[11]  D. Dieterich.  Long-term complications of nucleoside reverse transcriptase inhibitor therapy. , 2003, The AIDS reader.

[12]  W. Shearer,et al.  Medical Management of AIDS in Children , 2003 .

[13]  N. Ragni,et al.  Prospective study of mother‐to‐infant transmission of hepatitis C virus: a 10‐year survey (1990–2000) , 2003, Acta obstetricia et gynecologica Scandinavica.

[14]  F. Selvaggi,et al.  Effects of HIV-1 Tat protein on ion secretion and on cell proliferation in human intestinal epithelial cells. , 2003, Gastroenterology.

[15]  B. Amadi,et al.  Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial , 2002, The Lancet.

[16]  V. Sirisanthana,et al.  Cytomegalovirus-Associated Manifestations Involving the Digestive Tract in Children With Human Immunodeficiency Virus Infection , 2002, Journal of pediatric gastroenterology and nutrition.

[17]  P. Piliero,et al.  Case report. Hepatitis B virus and HIV coinfection. , 2002, The AIDS reader.

[18]  S. Ball.  Diarrhea in a patient with AIDS. , 2002, The AIDS reader.

[19]  P. Bessong,et al.  Diarrhoeagenic bacterial pathogens in HIV-positive patients with diarrhoea in rural communities of Limpopo Province, South Africa. , 2002, Journal of health, population, and nutrition.

[20]  C. Giaquinto,et al.  Effects of Nutritional Rehabilitation on Intestinal Function and on CD4 Cell Number in Children With HIV , 2002, Journal of Pediatric Gastroenterology and Nutrition - JPGN.

[21]  M. Farthing,et al.  Albendazole chemotherapy for AIDS‐related diarrhoea in Zambia—clinical, parasitological and mucosal responses , 2002, Alimentary pharmacology & therapeutics.

[22]  R. McCabe.  Gastrointestinal manifestations of non-AIDS immunodeficiency , 2002, Current treatment options in gastroenterology.

[23]  R. B. Canani,et al.  HIV, fatal rotavirus infection, and treatment options , 2002, The Lancet.

[24]  R. Chaisson,et al.  Hepatotoxicity associated with nevirapine or efavirenz‐containing antiretroviral therapy: Role of hepatitis C and B infections , 2002, Hepatology.

[25]  C. Azzari,et al.  Hepatitis C Virus Infection in Children Coinfected with HIV , 2002, Paediatric drugs.

[26]  D. Kimberlin.  Antiviral therapy for cytomegalovirus infections in pediatric patients. , 2002, Seminars in pediatric infectious diseases.

[27]  W. Fawzi,et al.  Vitamin A supplements ameliorate the adverse effect of HIV-1, malaria, and diarrheal infections on child growth. , 2002, Pediatrics.

[28]  W. Fawzi,et al.  Micronutrients and child health: studies in international nutrition and HIV infection. , 2009, Nutrition reviews.

[29]  A. Wu,et al.  Self‐Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection , 2001, Journal of acquired immune deficiency syndromes.

[30]  R. Guerrant,et al.  Cryptosporidiosis: an update. , 2001, The Lancet. Infectious diseases.

[31]  A. Elixhauser,et al.  Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception , 2001, The Lancet.

[32]  A. Guarino,et al.  Guidelines for the approach to outpatient children with acute diarrhoea , 2001, Acta paediatrica.

[33]  R. Berni Canani,et al.  Efficacy of oral pancreatic enzyme therapy for the treatment of fat malabsorption in HIV‐infected patients , 2001, Alimentary pharmacology & therapeutics.

[34]  E. Bini,et al.  Infectious diarrhea in human immunodeficiency virus. , 2001, Gastroenterology clinics of North America.

[35]  M. Molyneux,et al.  Effect of concomitant HIV infection on presentation and outcome of rotavirus gastroenteritis in Malawian children , 2001, The Lancet.

[36]  E. Orav,et al.  The effect of protease inhibitor therapy on growth and body composition in human immunodeficiency virus type 1-infected children. , 2001, Pediatrics.

[37]  M. Saag,et al.  The changing etiology of chronic diarrhea in HIV-infected patients with CD4 cell counts less than 200 cells/mm3 , 2000, American Journal of Gastroenterology.

[38]  D. Cooper,et al.  Adverse effects of antiretroviral therapy , 2000, The Lancet.

[39]  N. Klein,et al.  Immune repopulation after HAART in previously untreated HIV-1-infected children , 2000, The Lancet.

[40]  G. Noel,et al.  Energy balance, viral burden, insulin-like growth factor-1, interleukin-6 and growth impairment in children infected with human immunodeficiency virus , 2000, AIDS.

[41]  J. Church,et al.  Development of an instrument to assess nutritional risk factors for children infected with human immunodeficiency virus. , 2000, Journal of the American Dietetic Association.

[42]  M. Lindegren,et al.  Epidemiology of HIV/AIDS in children. , 2000, Pediatric clinics of North America.

[43]  K. Mönkemüller,et al.  Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy , 2000, American Journal of Gastroenterology.

[44]  T. Miller.  Nutrition in paediatric human immunodeficiency virus infection , 2000, Proceedings of the Nutrition Society.

[45]  A. Guarino,et al.  Ritonavir combination therapy restores intestinal function in children with advanced HIV disease. , 1999, Journal of acquired immune deficiency syndromes.

[46]  S. Zeichner,et al.  Handbook of Pediatric HIV Care , 1999 .

[47]  R. Owen,et al.  Small Intestine Pathogens in AIDS: Conventional and Opportunistic , 1998, Gastrointestinal Endoscopy Clinics of North America.

[48]  R. B. Canani,et al.  Pancreatic dysfunction and its association with fat malabsorption in HIV infected children , 1998, Gut.

[49]  A. Rubino,et al.  Enteric cryptosporidiosis in pediatric HIV infection. , 1997, Journal of pediatric gastroenterology and nutrition.

[50]  E. Orav,et al.  Endoscopy of the upper gastrointestinal tract as a diagnostic tool for children with human immunodeficiency virus infection. , 1997, The Journal of pediatrics.

[51]  W. Hanekom,et al.  Megestrol acetate treatment of growth failure in children infected with human immunodeficiency virus. , 1997, Pediatrics.

[52]  J. Cello,et al.  Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[53]  L. Rabeneck,et al.  AGA technical review: malnutrition and cachexia, chronic diarrhea, and hepatobiliary disease in patients with human immunodeficiency virus infection. , 1996, Gastroenterology.

[54]  W. Beisel.  Nutrition in pediatric HIV infection: setting the research agenda. Nutrition and immune function: overview. , 1996, The Journal of nutrition.

[55]  A. Rubino,et al.  Passive immunotherapy for rotavirus-induced diarrhoea in children with HIV infection. , 1996, AIDS.

[56]  J. Singer,et al.  A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group. , 1996, The New England journal of medicine.

[57]  A. Guarino,et al.  Iron deficiency and intestinal malabsorption in HIV disease. , 1996, Journal of pediatric gastroenterology and nutrition.

[58]  R. Yolken,et al.  Enteric pathogens associated with gastrointestinal dysfunction in children with HIV infection. , 1996, Molecular and cellular probes.

[59]  L. Welage,et al.  Alterations in gastric acidity in patients infected with human immunodeficiency virus. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[60]  K. Holmes,et al.  USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: introduction. USPHS/IDSA Prevention of Opportunistic Infections Working Group. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[61]  L. Koonin,et al.  Abortion surveillance--United States, 1991. , 1995, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[62]  A. Casola,et al.  Human intestinal cryptosporidiosis: secretory diarrhea and enterotoxic activity in Caco-2 cells. , 1995, The Journal of infectious diseases.

[63]  A. White,et al.  Intestinal function and injury in acquired immunodeficiency syndrome-related cryptosporidiosis. , 1995, Gastroenterology.

[64]  R. Owen,et al.  AIDS and the gut , 1994, Journal of gastroenterology and hepatology.

[65]  A. Rubino,et al.  Intestinal malabsorption of HIV‐infected children: relationship to diarrhoea, failure to thrive, enteric micro‐organisms and immune impairment The Italian Paediatric Intestinal/HIV Study Group* , 1993, AIDS.

[66]  D. Venzon,et al.  Pancreatitis in human immunodeficiency virus-infected children receiving dideoxyinosine. , 1993, Pediatrics.

[67]  N. Principi,et al.  Malabsorption of different lactose loads in children with human immunodeficiency virus infection. , 1992, Journal of Pediatric Gastroenterology and Nutrition - JPGN.

[68]  D. Thea,et al.  Persistent diarrhea associated with AIDS , 1992, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[69]  A. Plebani,et al.  Prognostic factors and survival in children with perinatal HIV-1 infection , 1992, The Lancet.

[70]  P. D’argenio,et al.  Malignancies in children with human immunodeficiency virus type 1 infection , 1991, Cancer.

[71]  A. Rubino,et al.  Impaired intestinal function in symptomatic HIV infection. , 1991, Journal of Pediatric Gastroenterology and Nutrition - JPGN.

[72]  N. Minton,et al.  Loperamide poisoning in children , 1990, The Lancet.

[73]  F. Daum,et al.  Textbook of pediatric gastroenterology , 1988 .